Description

Lansoprazole Dispersible Tablets / MUPS (15 mg / 30 mg)

Healthy Inc is a specialized global supplier and exporter of advanced gastroenterology, intensive care, and novel drug-delivery therapeutics. We provide ultra-high-purity, kinetically precise Lansoprazole Dispersible Tablets (15 mg / 30 mg) utilizing Multiple Unit Pellet System (MUPS) technology, manufactured in WHO–GMP certified, high-precision modified-release oral solid dosage facilities. This “Micro-Encapsulated Proton Pump Inhibitor” is a massive-volume, highly lucrative export to gastroenterology centers, pediatric hospitals, ICU networks, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally mandated, rapid-delivery intervention for severe Gastroesophageal Reflux Disease (GERD), erosive esophagitis, and acute peptic ulcers in patients who cannot swallow solid capsules.

Product Overview

This highly advanced formulation fundamentally solves the greatest challenge in PPI administration: delivering an acid-sensitive molecule to patients who cannot swallow intact pills. It utilizes elite micro-encapsulation to protect the active drug while allowing for liquid or feeding-tube administration.

The “Acid-Pump Blocker & MUPS Delivery” Specialist:

• Mechanism 1 (The Gastric H+/K+ ATPase Blockade): Lansoprazole is a highly potent, irreversible proton pump inhibitor. Once it absorbs in the alkaline duodenum and reaches the parietal cells of the stomach via the bloodstream, it covalently binds to the H+/K+ ATPase enzyme (the proton pump). This physically shuts down the final step of gastric acid secretion, dropping stomach acidity to near-zero and allowing severe bleeding ulcers and burned esophageal tissue to heal rapidly.
• Mechanism 2 (The MUPS Engineering Miracle – CRITICAL): Lansoprazole is instantly degraded by stomach acid. Standard capsules bypass this by holding enteric-coated granules. Our Dispersible Tablet utilizes Multiple Unit Pellet System (MUPS) technology. The tablet consists of thousands of microscopic, individually enteric-coated pellets compressed into a rapidly dispersing matrix. When placed in water (or the mouth), the tablet disintegrates in seconds, but the micro-pellets remain completely intact, forming a smooth suspension.
• Mechanism 3 (ICU & Pediatric Supremacy): This formulation is an absolute necessity in clinical settings. For a patient in the ICU on a nasogastric (NG) tube, or an infant with severe acid reflux, you cannot administer a standard solid capsule. The Lansoprazole DT can be dispersed in a small syringe of water and flushed directly down an NG tube without clogging the line or destroying the drug’s enteric protection.

Product Composition & Strength

We supply this product as a Precision-Blended, MUPS-Based Dispersible Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the delicate, moisture-sensitive micro-pellets.

*Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, highly monitored hospital and outpatient dispensing regimens).

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Gastroenterology Distributors, and Hospital Procurement Boards.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• MUPS Compression & Fluid-Bed Engineering (CRITICAL COMPLIANCE): The greatest risk in manufacturing a MUPS tablet is the compression phase. If the tablet press uses too much force, it will physically crack the microscopic enteric coatings on the pellets, causing the drug to be destroyed by stomach acid upon ingestion. Our facilities utilize advanced fluid-bed coating to build flexible, highly resilient polymeric shields around the API, followed by specialized low-force, cushioning excipient matrices. This guarantees that 100% of the micro-pellets survive the manufacturing process intact, delivering maximum clinical bioavailability.

Therapeutic Indications (Human Use)

Indicated for the targeted, highly specialized management of severe acid-related gastrointestinal disorders:

• Erosive Esophagitis & GERD: Short-term treatment and maintenance of healing for severe acid reflux and esophageal tissue damage.
• Gastric & Duodenal Ulcers: Rapid healing of active bleeding ulcers and prevention of NSAID-associated gastric ulcers.
• Helicobacter pylori Eradication: Used in triple-therapy regimens (with Clarithromycin and Amoxicillin) to eradicate the bacteria responsible for chronic ulcer disease.
• Zollinger-Ellison Syndrome: Long-term management of pathological hypersecretory conditions.

Dosage & Administration

Recommended Dosage (Strictly as per Gastroenterologist Guidelines):

• Administration (The Dispersion Protocol): The tablet should be placed in an oral syringe or a small cup with a small amount of water (e.g., 5 to 10 mL). Allow the tablet to completely disperse into a suspension (do not crush or chew the resulting pellets). The patient must drink the suspension immediately.
• Nasogastric (NG) Tube: Disperse the tablet in an oral syringe with water, shake gently, and flush immediately through the NG tube, followed by an additional water flush to clear the line.
• Timing: MUST be taken 30 minutes before a meal (typically breakfast) to ensure peak plasma levels coincide perfectly with the meal-induced activation of the stomach’s proton pumps.

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• Clostridium difficile-Associated Diarrhea: By removing stomach acid (the body’s primary bacterial defense), daily PPI therapy massive increases the risk of severe, persistent C. difficile intestinal infections.
• Bone Fractures & Osteoporosis: Long-term, high-dose use (over 1 year) significantly increases the risk of osteoporosis-related fractures of the hip, wrist, or spine.
• Severe Hypomagnesemia: Chronic use can cause a profound drop in blood magnesium levels, leading to fatal cardiac arrhythmias, tetany, and seizures.
• Vitamin B12 Deficiency: Stomach acid is required to cleave B12 from dietary protein. Prolonged use (over 3 years) can lead to severe B12 deficiency, causing irreversible neurological damage.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and Intensive Care Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Gastroenterology, MUPS Technology, and Dispersible Formulations. Whether you are looking for a reliable Government Tender Supplier for pediatric hospitals in Africa or a B2B Pharma Marketplace partner for Latin America, our highly regulated logistics network ensures timely, secure delivery of WHO-GMP certified products.